AI assistant
CONMED Corp — Director's Dealing 2013
Jun 4, 2013
31971_dirs_2013-06-04_cbaa33c9-24c3-45c7-8007-52245f9909f6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-06-01
Reporting Person: SHALLISH ROBERT D JR (Vice President/Finance/CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 40771 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 40481 | Direct |
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 41281 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 40991 | Direct |
| 2013-06-01 | Common Stock | M | 1200 | — | Acquired | 42191 | Direct |
| 2013-06-01 | Common Stock | F | 435 | $32.93 | Disposed | 41756 | Direct |
| 2013-06-01 | Common Stock | M | 1200 | — | Acquired | 42956 | Direct |
| 2013-06-01 | Common Stock | F | 435 | $32.93 | Disposed | 42521 | Direct |
| 2013-06-01 | Common Stock | M | 1200 | — | Acquired | 43721 | Direct |
| 2013-06-01 | Common Stock | F | 435 | $32.93 | Disposed | 43286 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2018-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2019-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 1200 | Disposed | 2020-06-01 | Common Stock (1200) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 1200 | Disposed | 2021-06-01 | Common Stock (1200) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 1200 | Disposed | 2022-06-01 | Common Stock (1200) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | A | 7000 | Acquired | 2023-06-01 | Common Stock (7000) | Direct |
| 2013-06-01 | Sars (Stock Appreciation Rights) | $32.93 | A | 15000 | Acquired | 2023-06-01 | Common Stock (15000) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.